Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma

Abstract This study investigated the prognostic impact of migrasome-related long noncoding RNAs (lncRNAs) in lung adenocarcinoma (LUAD). We analyzed transcriptomic data from The Cancer Genome Atlas (TCGA) database, comprising 541 tumor samples and 59 normal tissue samples, to pinpoint key migrasome...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Zhao, Kunpeng Yang, Yuejiao Lan, Mingda Wu, Lei Wang, Chenglun Cai, Peiyun Lv, Wenjuan Sun, Xiaodan Lu, Bao Wang
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-03000-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238394138263552
author Hui Zhao
Kunpeng Yang
Yuejiao Lan
Mingda Wu
Lei Wang
Chenglun Cai
Peiyun Lv
Wenjuan Sun
Xiaodan Lu
Bao Wang
author_facet Hui Zhao
Kunpeng Yang
Yuejiao Lan
Mingda Wu
Lei Wang
Chenglun Cai
Peiyun Lv
Wenjuan Sun
Xiaodan Lu
Bao Wang
author_sort Hui Zhao
collection DOAJ
description Abstract This study investigated the prognostic impact of migrasome-related long noncoding RNAs (lncRNAs) in lung adenocarcinoma (LUAD). We analyzed transcriptomic data from The Cancer Genome Atlas (TCGA) database, comprising 541 tumor samples and 59 normal tissue samples, to pinpoint key migrasome genes and related lncRNAs, using correlation analysis to detect those pertinent to patient outcomes. A risk score model based on 17 migrasome-related lncRNAs, constructed via univariate, LASSO, and multivariate Cox regression, was then validated in an independent dataset to ensure reliability. Our findings revealed that high-risk patients exhibited worse overall and progression-free survival, alongside altered immune features, such as potential immune evasion and an increased propensity for immunotherapy responsiveness. Moreover, Tumor Immune Dysfunction and Exclusion (TIDE) analyses suggested that individuals with higher scores could experience greater benefit from immune checkpoint inhibitors. Functional enrichment analysis supported the engagement of migrasome-related pathways and immune-regulatory processes that may drive disease progression. Additionally, principal component analysis (PCA) confirmed the robustness of our lncRNA-driven classifier, enabling accurate differentiation of risk cohorts. Overall, our study underscores the contribution of migrasome-related lncRNAs in predicting LUAD prognosis and informing clinical choices, shedding light on tumor biology and immunotherapy response. These results emphasize the clinical importance of migrasome-related lncRNAs as promising therapeutic targets and prognostic biomarkers in LUAD management.
format Article
id doaj-art-a21d907c824248a3b17dad99d00f09a5
institution Kabale University
issn 2730-6011
language English
publishDate 2025-06-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-a21d907c824248a3b17dad99d00f09a52025-08-20T04:01:36ZengSpringerDiscover Oncology2730-60112025-06-0116112010.1007/s12672-025-03000-5Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinomaHui Zhao0Kunpeng Yang1Yuejiao Lan2Mingda Wu3Lei Wang4Chenglun Cai5Peiyun Lv6Wenjuan Sun7Xiaodan Lu8Bao Wang9Jilin Cancer HospitalJilin Cancer HospitalPrecision Medicine Center, Jilin People’s HospitalPrecision Medicine Center, Jilin People’s HospitalJilin Cancer HospitalJilin Cancer HospitalJilin Cancer HospitalChangchun University of Chinese MedicinePrecision Medicine Center, Jilin People’s HospitalJilin Cancer HospitalAbstract This study investigated the prognostic impact of migrasome-related long noncoding RNAs (lncRNAs) in lung adenocarcinoma (LUAD). We analyzed transcriptomic data from The Cancer Genome Atlas (TCGA) database, comprising 541 tumor samples and 59 normal tissue samples, to pinpoint key migrasome genes and related lncRNAs, using correlation analysis to detect those pertinent to patient outcomes. A risk score model based on 17 migrasome-related lncRNAs, constructed via univariate, LASSO, and multivariate Cox regression, was then validated in an independent dataset to ensure reliability. Our findings revealed that high-risk patients exhibited worse overall and progression-free survival, alongside altered immune features, such as potential immune evasion and an increased propensity for immunotherapy responsiveness. Moreover, Tumor Immune Dysfunction and Exclusion (TIDE) analyses suggested that individuals with higher scores could experience greater benefit from immune checkpoint inhibitors. Functional enrichment analysis supported the engagement of migrasome-related pathways and immune-regulatory processes that may drive disease progression. Additionally, principal component analysis (PCA) confirmed the robustness of our lncRNA-driven classifier, enabling accurate differentiation of risk cohorts. Overall, our study underscores the contribution of migrasome-related lncRNAs in predicting LUAD prognosis and informing clinical choices, shedding light on tumor biology and immunotherapy response. These results emphasize the clinical importance of migrasome-related lncRNAs as promising therapeutic targets and prognostic biomarkers in LUAD management.https://doi.org/10.1007/s12672-025-03000-5LncRNAsLUADMigrasomesPrognosisImmunotherapy
spellingShingle Hui Zhao
Kunpeng Yang
Yuejiao Lan
Mingda Wu
Lei Wang
Chenglun Cai
Peiyun Lv
Wenjuan Sun
Xiaodan Lu
Bao Wang
Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
Discover Oncology
LncRNAs
LUAD
Migrasomes
Prognosis
Immunotherapy
title Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
title_full Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
title_fullStr Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
title_full_unstemmed Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
title_short Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
title_sort influence of migrasome associated long noncoding rnas on the immune microenvironment and prognosis in lung adenocarcinoma
topic LncRNAs
LUAD
Migrasomes
Prognosis
Immunotherapy
url https://doi.org/10.1007/s12672-025-03000-5
work_keys_str_mv AT huizhao influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT kunpengyang influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT yuejiaolan influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT mingdawu influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT leiwang influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT chengluncai influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT peiyunlv influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT wenjuansun influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT xiaodanlu influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma
AT baowang influenceofmigrasomeassociatedlongnoncodingrnasontheimmunemicroenvironmentandprognosisinlungadenocarcinoma